These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25941701)

  • 1. Topical minoxidil: accidental poisoning in children.
    Prescrire Int; 2015 Apr; 24(159):97. PubMed ID: 25941701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdose of Rogaine Extra Strength for Men topical minoxidil preparation.
    Farrell SE; Epstein SK
    J Toxicol Clin Toxicol; 1999; 37(6):781-3. PubMed ID: 10584592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Minoxidil intoxication, the pharmacological agent of a hair lotion].
    Aprahamian A; Escoda S; Patteau G; Merckx A; Chéron G
    Arch Pediatr; 2011 Dec; 18(12):1302-4. PubMed ID: 22001642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minoxidil 5% solution for topical treatment of loose anagen hair syndrome.
    Chandran NS; Oranje AP
    Pediatr Dermatol; 2014; 31(3):389-90. PubMed ID: 24602086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory hypotension due to Rogaine® (minoxidil) ingestion managed with midodrine.
    Garrard A; Wood A; Sollee D; Aaronson P
    Clin Toxicol (Phila); 2011 Dec; 49(10):907-9. PubMed ID: 22077158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical use of minoxidil in children and systemic side effects.
    Georgala S; Befon A; Maniatopoulou E; Georgala C
    Dermatology; 2007; 214(1):101-2. PubMed ID: 17191059
    [No Abstract]   [Full Text] [Related]  

  • 7. Minoxidil topical solution: an unsafe product for children.
    Claudet I; Cortey C; Honorat R; Franchitto N
    Pediatr Emerg Care; 2015 Jan; 31(1):44-6. PubMed ID: 25426682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minoxidil overdose.
    MacMillan AR; Warshawski FJ; Steinberg RA
    Chest; 1993 Apr; 103(4):1290-1. PubMed ID: 8131492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vacuum constriction device and topical minoxidil for management of impotence.
    Cecchi M; Sepich CA; Felipetto R; Vigano L; Pagni G; Minervini R; Fiorentini L
    Arch Esp Urol; 1995 Dec; 48(10):1058-9. PubMed ID: 8588728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy.
    Benmously Mlika R; Ben Hamida M; Hammami H; Dorbani Ben Thabet I; Rouatbi M; Mokhtar I
    J Cosmet Laser Ther; 2013 Aug; 15(4):217-8. PubMed ID: 23463948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of minoxidil toxicosis in a dog.
    Jordan TJM; Yaxley PE; Culler CA; Balakrishnan A
    J Am Vet Med Assoc; 2018 Jan; 252(2):222-226. PubMed ID: 29319439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between treatment efficacy and cumulative dose of 3% topical minoxidil in male pattern baldness.
    Choi JW; Na SY; Park KC; Youn SW; Huh CH
    J Am Acad Dermatol; 2012 Jan; 66(1):e10-2. PubMed ID: 22177646
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of minoxidil in Espumil foam base.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(2):165-7. PubMed ID: 23696178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
    Hagemann T; Schlütter-Böhmer B; Allam JP; Bieber T; Novak N
    Contact Dermatitis; 2005 Jul; 53(1):53-5. PubMed ID: 15982234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of topical minoxidil solution: a one-year, prospective, observational study.
    Shapiro J
    J Cutan Med Surg; 2003; 7(4):322-9. PubMed ID: 14735400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minoxidil overdose with ECG changes: case report and review.
    Poff SW; Rose SR
    J Emerg Med; 1992; 10(1):53-7. PubMed ID: 1629592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of topical minoxidil to accelerate nail growth: a pilot study.
    Aiempanakit K; Geater A; Limtong P; Nicoletti K
    Int J Dermatol; 2017 Jul; 56(7):788-791. PubMed ID: 28436015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
    Silva AC; Santos D; Ferreira DC; Souto EB
    Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaneuron: an oral solution of phenobarbital with dangerous packaging.
    Prescrire Int; 2015 Apr; 24(159):95. PubMed ID: 25941699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
    Tosti A; Iorizzo M; Vincenzi C
    Arch Dermatol; 2003 Sep; 139(9):1221-2. PubMed ID: 12975176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.